Drugs / Euvax B vaccine
Euvax B vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01468051 | Oct 2008 | chronic renal failure syndrome | Tehran University of Medical Sciences | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Euvax B vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01468051 ↗ |
| Known as | Euvax B vaccine (recombinant hepatitis B surface antigen adsorbed on aluminium hydroxide adjuvant- LG Chem, Korea) | “Euvax B vaccine (recombinant hepatitis B surface antigen adsorbed on aluminium hydroxide adjuvant- LG Chem, Korea)” NCT01468051 ↗ |
| Modality | Vaccine | “Euvax B recombinant hepatitis B surface antigen (HBsAg) vaccine” NCT01468051 ↗ |